Showing 501-510 of 2123 results for "".
- How Will Genomics Affect the Practice of Neurology?https://practicalneurology.com/columns/practice-management/how-will-genomics-affect-the-practice-of-neurology/31116/Genomics is increasingly revolutionizing the field of neurology, transforming both the understanding and treatment of neurological disorders. Since the completion of the human genome mapping in 2003, advancements in structural and functional genomics have provided deep insights into gene sequences,
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31110/Adrenal insufficiency remains a significant clinical concern, particularly in patients undergoing long-term glucocorticoid therapy for conditions such as multiple sclerosis (MS). A pertinent case involves a 54-year-old woman with a decade-long history of primary progressive MS, managed with monthly
- Keeping Stroke Patients Safe and Securehttps://practicalneurology.com/diseases-diagnoses/stroke/pn0807-stroke-fea-pdf/31139/Surviving an ischemic stroke brings immediate relief for patients, yet it introduces lifelong vulnerabilities, notably the risk of recurrent and potentially more severe strokes. Effective supportive care for stroke survivors centers on two primary objectives: minimizing injury to ischemic brain tiss
- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0507ExpertOp-pdf/31176/Atypical Antipsychotics in Alzheimer’s Disease: Balancing Efficacy and SafetyIn a case report by Dr. Richard M. Sobel, a 79-year-old patient with Alzheimer’s disease (AD) exhibits progressive cognitive decline accompanied by memory loss, confusion, delusions of theft, and occasional combativeness. D
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31196/Intravenous thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke has been FDA approved for over a decade, yet its status as the standard of care within the three-hour window remains debated among neurologists. Critics often cite the original NINDS tPA trials' limited sample
- Avoiding Medicolegal Headaches in Migraine Carehttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1006medicolegal-pdf/31261/Migraine remains a highly prevalent yet complex neurological condition, presenting significant challenges in diagnosis and management for healthcare professionals. Unlike more straightforward ailments, migraines exhibit a wide spectrum of symptoms and classifications as outlined in the International
- Growing Pains: Treating Migraine in Teens and Adolescentshttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0906GrowingPainsFEA-pdf/31271/Migraine during adolescence presents significant challenges, affecting over 10% of teenagers as they navigate physiological and social changes. The onset of migraine frequently begins in the teenage years, with females more likely to experience their first episode. Migraines with aura typically emer
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31353/Enhancing Acute Stroke Care: Bridging the Gap Between Potential and PracticeIn the January 2006 issue of *Practical Neurology*, Editor-in-Chief Jack Persico addresses the persistent challenges in acute stroke care, particularly the administration of tissue plasminogen activator (tPA). Four years aft
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1005painmanagement-pdf/31391/Comprehensive Management of Lower Back Pain with Radiculopathy: A Clinical Case StudyIn Practical Neurology's October 2005 issue, a compelling case highlights the intricate decision-making involved in managing acute lower back pain with radiculopathy. Patient S. Rogers, a 54-year-old carpenter, pres
- Point-Counterpoint: Is Revascularization Warranted to Prevent Stroke In Asymptomatic Stenosis?https://practicalneurology.com/diseases-diagnoses/stroke/PN0905_Stenosis_Intro-pdf/31407/Carotid Stenosis Management: Evolving Strategies and Ongoing DebatesCarotid stenosis, a significant risk factor for ischemic stroke, has been a focal point in neurology for over fifty years. Initially identified in the mid-20th century, the primary intervention for this condition has been carotid en